Akanksha Singh
Akanksha Singh has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Doha Mahmoud Mhaoesh
Department of Internal Medicine, Emam Abdulrahman Alfaisal Hospital, Riyadh, Saudi Arabia
2 shared publications - Mohammed Abdul Mateen
Department of Internal Medicine, Shadan Institute of Medical Sciences, Teaching Hospital and Research Centre, Hyderabad, India
2 shared publications - Trisha Shivashankar
Department of Internal Medicine, Bharati Vidyapeeth University Medical College, Pune, India
2 shared publications - Aayush Sangwan
Department of Internal Medicine, NCR Institute of Medical Sciences, Meerut, India
1 shared publication - Adithya Andanappa
Department of Internal Medicine, Mysore Medical College and Research Institute, Mysore, India
1 shared publication - Chiranjeevee Ramanathan Mbbs Saravanan
Internal Medicine, Madras Medical College, Chennai, India
1 shared publication
Latest Publications
- Open Access
- 27 April 2026
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 88 (6) , 3695-3699
Early recognition and successful management of dermatomyositis-systemic lupus erythematosus overlap syndrome: case study of a young adult
Introduction and importance: An overlap syndrome is a condition when there is coexistence of two or more autoimmune connective tissue disease, which is very rare and diagnostically challenging. Dermatomyositis is an autoimmune condition that presents with skin manifestations, progressive muscular weakness, and inflammation. Systemic lupus erythematosus (SLE) is a chronic multisystem autoimmune condition mainly affecting skin, joints, kidneys, and brain. Early recognition and therapeutic intervention are necessary in overlap syndromes to prevent the patient from having severe cardiopulmonary problems. Case presentation: This is a case of a 32-year-old woman diagnosed with SLE who developed progressive muscle weakness (3/5 strength proximally) and a distinctive rash, classic signs of dermatomyositis from last 2 months. Laboratory tests have shown elevated creatine kinase (3500 U/l), positive ANA (1:640), anti-dsDNA, and anti-Jo-1 antibodies, along with visible myopathic alterations on electromyographs; unique results on muscle and skin biopsies were all confirmed by investigations. Clinical discussion: After confirming the diagnosis of dermatomyositis, the patient condition was managed by high dose corticosteroids (prednisolone 1 mg/kg/day), intravenous immunoglobulin for severe muscle weakness, methotrexate, high-dose corticosteroids, and physical therapy. Conclusion: This case highlights the complexity of diagnosis in distinguishing the true dermatomyositis from SLE associated inflammatory myopathy in young adults. It emphasizes the importance of early recognition of DM-SLE overlap syndrome through targeted investigations integrating clinical, serological, and histopathological assessment; that can alter the disease trajectory. The case emphasizes the importance of maintaining high clinical suspicion in patients with autoimmune diseases while guiding the immunosuppressive therapy.
- 27 April 2026
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 88 (6) , 3695-3699
Open AccessEarly recognition and successful management of dermatomyositis-systemic lupus erythematosus overlap syndrome: case study of a young adult
Introduction and importance: An overlap syndrome is a condition when there is coexistence of two or more autoimmune connective tissue disease, which is very rare and diagnostically challenging. Dermatomyositis is an autoimmune condition that presents with skin manifestations, progressive muscular weakness, and inflammation. Systemic lupus erythematosus (SLE) is a chronic multisystem autoimmune condition mainly affecting skin, joints, kidneys, and brain. Early recognition and therapeutic intervention are necessary in overlap syndromes to prevent the patient from having severe cardiopulmonary problems. Case presentation: This is a case of a 32-year-old woman diagnosed with SLE who developed progressive muscle weakness (3/5 strength proximally) and a distinctive rash, classic signs of dermatomyositis from last 2 months. Laboratory tests have shown elevated creatine kinase (3500 U/l), positive ANA (1:640), anti-dsDNA, and anti-Jo-1 antibodies, along with visible myopathic alterations on electromyographs; unique results on muscle and skin biopsies were all confirmed by investigations. Clinical discussion: After confirming the diagnosis of dermatomyositis, the patient condition was managed by high dose corticosteroids (prednisolone 1 mg/kg/day), intravenous immunoglobulin for severe muscle weakness, methotrexate, high-dose corticosteroids, and physical therapy. Conclusion: This case highlights the complexity of diagnosis in distinguishing the true dermatomyositis from SLE associated inflammatory myopathy in young adults. It emphasizes the importance of early recognition of DM-SLE overlap syndrome through targeted investigations integrating clinical, serological, and histopathological assessment; that can alter the disease trajectory. The case emphasizes the importance of maintaining high clinical suspicion in patients with autoimmune diseases while guiding the immunosuppressive therapy.
- Open Access
- 14 July 2025
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 87 (9) , 6072-6077
Multidisciplinary approach to Klippel–Trenaunay syndrome: a case report
Klippel–Trenaunay syndrome (KTS) is a rare inherited disorder presenting as a triad of capillary malformations (cutaneous hemangiomas), soft tissue hypertrophy, and varicosities. Two out of three signs are enough to make a diagnosis. It is associated with gastrointestinal, hematological, neuro-ophthalmic, dermatological, pulmonary, oro-dental, renal cardiac, and vascular complications. There is no curative treatment for the disease. Complications are currently managed symptomatically and thorough documentation of all signs and symptoms is essential for timely identification and management of potential complications, thereby improving patient outcomes. KTS was diagnosed in a 16-year-old female, with dyspnea and fever associated with hemoptysis and abdominal pain. On physical examination, cutaneous findings and signs of respiratory compromise as well as evidence of vascular disease were observed. After appropriate medical care, the patient was soon discharged from the hospital. Following initial treatment, the patient’s symptoms arbitrarily recurred requiring continued medical management and blood product administration to manage complications resulting from KTS. KTS is a chronic disorder with no cure. Patients with KTS are managed symptomatically and require frequent hospitalizations for the same.
- 14 July 2025
- Published by Wolters Kluwer Health in Annals of Medicine & Surgery
- Vol. 87 (9) , 6072-6077
Open AccessMultidisciplinary approach to Klippel–Trenaunay syndrome: a case report
Klippel–Trenaunay syndrome (KTS) is a rare inherited disorder presenting as a triad of capillary malformations (cutaneous hemangiomas), soft tissue hypertrophy, and varicosities. Two out of three signs are enough to make a diagnosis. It is associated with gastrointestinal, hematological, neuro-ophthalmic, dermatological, pulmonary, oro-dental, renal cardiac, and vascular complications. There is no curative treatment for the disease. Complications are currently managed symptomatically and thorough documentation of all signs and symptoms is essential for timely identification and management of potential complications, thereby improving patient outcomes. KTS was diagnosed in a 16-year-old female, with dyspnea and fever associated with hemoptysis and abdominal pain. On physical examination, cutaneous findings and signs of respiratory compromise as well as evidence of vascular disease were observed. After appropriate medical care, the patient was soon discharged from the hospital. Following initial treatment, the patient’s symptoms arbitrarily recurred requiring continued medical management and blood product administration to manage complications resulting from KTS. KTS is a chronic disorder with no cure. Patients with KTS are managed symptomatically and require frequent hospitalizations for the same.